l-Dopa withdrawal in Parkinson's disease selectively impairs cognitive performance in tests sensitive to frontal lobe dysfunction
- Journal
- Psychopharmacology
In The Last Decade
doi.org/10.1007/bf02245167 →Countries where authors are citing l-Dopa withdrawal in Parkinson's disease selectively impairs cognitive performance in tests sensitive to frontal lobe dysfunction
This map shows the geographic impact of l-Dopa withdrawal in Parkinson's disease selectively impairs cognitive performance in tests sensitive to frontal lobe dysfunction. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by l-Dopa withdrawal in Parkinson's disease selectively impairs cognitive performance in tests sensitive to frontal lobe dysfunction with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites l-Dopa withdrawal in Parkinson's disease selectively impairs cognitive performance in tests sensitive to frontal lobe dysfunction more than expected).
Fields of papers citing l-Dopa withdrawal in Parkinson's disease selectively impairs cognitive performance in tests sensitive to frontal lobe dysfunction
This network shows the impact of l-Dopa withdrawal in Parkinson's disease selectively impairs cognitive performance in tests sensitive to frontal lobe dysfunction. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the l-Dopa withdrawal in Parkinson's disease selectively impairs cognitive performance in tests sensitive to frontal lobe dysfunction.
About l-Dopa withdrawal in Parkinson's disease selectively impairs cognitive performance in tests sensitive to frontal lobe dysfunction
This paper, published in 1992, received 500 indexed citations . Written by Klaus W. Lange, Trevor W. Robbins, C. D. Marsden, Martin James, Adrian M. Owen and Gesine Paul covering the research area of Neurology and Psychiatry and Mental health. It is primarily cited by scholars working on Cognitive Neuroscience (269 citations), Neurology (220 citations) and Cellular and Molecular Neuroscience (115 citations). Published in Psychopharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
This paper is also available at doi.org/10.1007/bf02245167.